Successful liver transplantation for hilar cholangiocarcinoma

Current Opinion in Gastroenterology

Volumn 24, Issue 3, 2008, Pages 384-388

  Heimbach, Julie K ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bile duct cancer; Hilar cholangiocarcinoma; Liver transplantation; Survival analysis

Indexed keywords

CAPECITABINE; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTERY DISEASE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HEPATIC ARTERY STRICTURE; HEPATIC ARTERY THROMBOSIS; HUMAN; LIVER SURGERY; LIVER TRANSPLANTATION; ORGAN DONOR; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; VASCULAR DISEASE;

BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER TRANSPLANTATION; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 42149097140     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282f706ce     Document Type: Review

References (32)

1. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463-473; discussion 473-475.
2. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 1996; 224:628-638.
3. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663-671.
4. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 2001; 234:270-276.
5. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-517; discussion 517-519.
6. Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993; 166:768-771; discussion 771-772.
7. Jonas S, Kling N, Guckelberger O, et al. Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma: first long-term results. Transpl Int 1998; 11 (Suppl 1):S206-S208.
8. Loinaz C, Abradelo M, Gomez R, et al. Liver transplantation and incidental primary liver tumors. Transplant Proc 1998; 30:3301-3302.
9. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187:358-364.
10. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69:1633-1637.
11. Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 2001; 12:1023-1033.
12. Robles R, Figueras J, Turrion VA, et al. Liver transplantation for hilar cholangiocarcinoma: Spanish experience. Transpl Proc 2003; 35:1821-1822.
13. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 2005; 11:1412-1416.
14. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6:309-316.
15. Hassoun Z, Gores GJ, Rosen CB, et al. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am 2002; 11:909-921.
16. Heimbach JK, Gores GJ, Haddock MG, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24:201-207.
17. Sudan D, DeRoover A, Chinnakotia S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transpl 2002; 2:774-779.
18. Rea D, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 3:451-461.
19. Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 12:1703-1707. This article is the first investigation of the predictors of disease recurrence following liver transplantation for hilar cholangiocarcinoma and may be helpful in guiding patient selection.
20. Yokoyama Y, Nagina M, Nishio H, et al. Recent advances in the treatment of hilar cholangiocarcinoma: portal vein embolization. J Hepatobiliary Pancreat Surg 2007; 14:447-454.
21. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 5:755-762. This report provides a perspective on anticipated outcomes following resection at a single center with a large series of patients followed over a prolonged time period.
22. Miyazaki M, Kato A, Ito H, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 2007; 5:581-588.
23. Hasegawa S, Ikai I, Fujii H, et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 2007; 31:1256-1263.
24. Hemming AW, Kim RD, Mekeel KL, et al. Portal vein resection for hilar cholangiocarcinoma. Am Surg 2006; 72:599-605. This report provides recent outcomes with resection utilizing techniques to enhance resectability such as portal vein reconstruction and demonstrates survival rates for those with a complete resection of 45% at 5 years.
25. Nathan H, Pawlik TM, Wolfgang CL, et al. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 2007; 11:1488-1497.
26. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995; 31:1213-1236.
27. Cheng SW, Ting AC, Ho P, Wu LL. Accelerated progression of carotid stenosis with previous external neck irradiation. J Vasc Surg 2004; 39:409-415.
28. Thelen A, Neuhaus P. Liver transplantation for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2007; 12:469-475.
29. Mantel HTJ, Rosen CB, Heimbach JK, et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007; 12:1372-1381. This is the first report to describe the identification and management of the unique vascular complications seen after the combined neoadjuvant therapy OLT protocol, which is information that would be helpful for any center considering initiating such a protocol.
30. Becker NS, Rodriguez JA, Barshes NR, et al. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 2007; 26 October [Epub ahead of print]. This is the recent report using multicenter data to report on outcomes following liver transplantation for cholangiocarcinoma. It is only limited by the lack of information regarding the use of preoperative adjuvant therapy.
31. Gores GJ, Gish RG, Sudan D, Rosen CB, MELD Exception Study Group. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 2006; 12:S95-S97. This report is authored by a consensus group and considers the current data available on transplantation for hilar cholangiocarcinoma in the context of an appropriate MELD adjustment.
32. Gores GJ, Nagorney DM, Rosen CB. Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 2007; 47:454-475. This review highlights recent advances in the diagnosis of cholangiocarcinoma as well as providing a compelling discussion of the role of transplantation in resectable as well as unresectable disease, in addition to discussing timing of transplantation and allocation issues.